Blackbaud (BLKB) stock is back in focus after the company introduced a Chart of Accounts Health Advisor for its Financial Edge NXT platform, a product update aimed at nonprofit finance teams seeking clearer, more actionable financial data.

Despite the product launch and the recent $68.4 million shelf registration tied to an ESOP offering, Blackbaud's share price return is down 52.94% year to date and the 5 year total shareholder return is down 64.15%. This suggests momentum has been weak even as new tools are introduced.

If this kind of product focused story has you thinking about where else software and automation could reshape industries, it may be worth scanning 32 robotics and automation stocks

With Blackbaud stock trading at US$28.01 alongside an indicated intrinsic discount of 66.5% and a wide gap to analyst targets, the key question is whether this signals a genuine opportunity or simply reflects markets already pricing in future growth.

Most Popular Narrative: 45.1% Undervalued

With Blackbaud stock at $28.01 against a widely followed fair value anchor of $51.00, the current gap frames a valuation story built around measured growth, margin expectations and disciplined capital returns.

The shift toward cloud-based SaaS subscription models and improvements in operational efficiency, including automation and AI-driven internal initiatives, are lowering costs and improving gross and net margins, providing significant leverage to long-term earnings growth.

Read the complete narrative. Read the complete narrative.

Curious what kind of revenue glide path, margin step up and future earnings multiple are required to justify that $51.00 line in the sand? The most popular Blackbaud narrative leans on a specific mix of steady top line expansion, firmer profitability and a re rated P/E to make the numbers stack up, and the details behind those assumptions may change how you read today’s share price.

Result: Fair Value of $51 (UNDERVALUED)

However, Blackbaud's story also has pressure points, including rising competition from large SaaS players and the risk that ongoing AI and security spend will squeeze margins.

Next Steps

With sentiment clearly mixed for Blackbaud, with concerns on one side and optimism on the other, it makes sense to look through the data yourself and move quickly. To see both sides laid out in one place, review the 5 key rewards and 1 important warning sign

Looking for more investment ideas beyond Blackbaud?

If Blackbaud has sharpened your interest in valuations and future potential, do not stop here. Broaden your watchlist now so you do not miss potential opportunities.

• Target resilient compounders by scanning companies with dependable balance sheets and fundamentals using the solid balance sheet and fundamentals stocks screener (48 results).
• Look for possibly mispriced opportunities by reviewing the 44 high quality undervalued stocks that combines quality metrics with current pricing.
• Prioritise relatively lower-risk holdings with the 67 resilient stocks with low risk scores, which screens for stocks presenting lower overall risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.